We're probably at the peak of the AI hype cycle. Your teams have moved beyond experimenting with ChatGPT—they're now integrating AI into...

💊 Bristol-Myers Squibb and Pfizer  are rolling out DTC sales for Eliquis—one of the world’s best-selling blood thinners—at a discount....

Is pharma finally getting AI governance right? After years of cautious experimentation, pharmaceutical companies are finding their rhythm...

The AI-powered drug discovery  platform market is set to reach $1.29 billion in 2025, and surge to $8.27 billion by 2035—a rapid ~20%...

What if the success of AI in pharma R&D depends less on how powerful the models are—and more on whether companies build the right...